NCT04417283

Brief Summary

The purpose of this study is to collect biological samples from pregnant women and their babies and to collect data on long-term health, school outcomes, and the use of state and county services. The information learned from this study may help identify important factors that may influence the health of mothers and babies, both short-and long-term.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
10mo left

Started Nov 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Nov 2018Mar 2027

Study Start

First participant enrolled

November 21, 2018

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

June 2, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 4, 2020

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 22, 2024

Completed
2.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Expected
Last Updated

August 11, 2025

Status Verified

August 1, 2025

Enrollment Period

6 years

First QC Date

June 2, 2020

Last Update Submit

August 7, 2025

Conditions

Keywords

PregnancyGestationPlacentaExposureEnvironmentSocial Drivers of HealthInfancyBiological specimensElectronic health records

Outcome Measures

Primary Outcomes (1)

  • Development of a data repository to provide a secure, centralized storage location for samples from pregnant women.

    Up to 2 years

Study Arms (1)

Mother-infant dyads

Mother and/or infant participants will provide a series of biological specimens, including blood, urine, and microbiome samples. Additionally, each participant will wear a silicone wrist band each trimester to capture environmental exposures and will fill out study surveys related to diet, environmental exposures, and social factors.

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPregnant participants can enroll in the first or second trimester of pregnancy
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Mother and/or infant participants will provide a series of biological specimens, including blood, urine, and microbiome samples. Additionally, each participant will wear a silicone wrist band each trimester to capture environmental exposures and will fill out study surveys related to diet, environmental exposures, and social factors.

You may qualify if:

  • The subject has provided a signed Informed consent prior to any study procedures.
  • Maternal age at consent of ≥ 18 years old
  • Ability to understand English or Spanish
  • Willingness to comply with and be available for all protocol procedures
  • Singleton gestation \< 24 weeks 0 days
  • Receiving prenatal care at a Duke-affiliated Obstetrics clinic with the intent of delivering at Duke University Health System-affiliated hospital (including Duke University Hospital and Duke Regional Hospital)
  • Plans to have their infant seen at a Duke-affiliated Pediatrics practice after birth
  • Plans to remain in the area for two years after delivery

You may not qualify if:

  • Non-viable pregnancy
  • Having any condition that, in the opinion of the site investigators, would place the subject at unacceptable risk of injury or confound data interpretation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke affiliated ObGyn clinics within Duke Health

Durham, North Carolina, 27710, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

Blood will be collected.

Study Officials

  • Jennifer Gilner, MD

    Duke University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 2, 2020

First Posted

June 4, 2020

Study Start

November 21, 2018

Primary Completion

November 22, 2024

Study Completion (Estimated)

March 1, 2027

Last Updated

August 11, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations